Companies: 10,795·Total market cap: $144.5T
Life Stem Genetics Inc.

Life Stem Genetics Inc.

LIFSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4584
P/E Ratio
52W High$0.0003
52W Low$0.0001

Life Stem Genetics Inc. (LIFS) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · LIFS · as of 2026-06-08

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-062024-06
Revenue
Revenue$0.00B$0.00B
Cost of Revenue$0.00B$0.00B
Gross Profit$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.00B$0.00B
G&A Expenses$0.00B$0.00B
Total Operating Expenses$0.00B$0.00B
Operating Income($0.00B)($0.00B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B
Interest Expense$0.00B$0.00B
Income Before Tax($0.00B)($0.00B)
Income Tax Expense$0.00B$0.00B
Net Income($0.00B)($0.00B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$0.00$-0.00
Wtd Avg Shares0.25B0.25B
EBITDA($0.00B)($0.00B)
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B

Explore more Life Stem Genetics Inc. data

About Life Stem Genetics Inc. (LIFS) Income Statement

Life Stem Genetics Inc. (LIFS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, LIFS reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.00B) — a net profit margin of —.

Frequently asked questions

LIFS · 4 questions

Life Stem Genetics Inc. (LIFS) reported revenue of $0.00B for 2025, down —% year-over-year.

LIFS revenueLIFS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08